Immune Checkpoint Inhibitors for the Treatment of Unresectable Stage III Non–Small Cell Lung Cancer: Emerging Mechanisms and Perspectives
Lung Cancer: Targets and Therapy · 2020-01 · Volume 10 · 161-170
DOI: 10.2147/lctt.s184380 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Lung Cancer: Targets and Therapy, 2020-01. Verfasst von Hiroyuki Inoue und 1 weiteren Autor:innen. Beteiligte Einrichtung: Research Institute for Diseases of the Chest, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan. Die Arbeit wurde bisher 4-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Research Institute for Diseases of the Chest, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
- Center for Clinical and Translational Research, Kyushu University Hospital, Fukuoka, Japan.
Zitieren
APA
Inoue, H., & Okamoto, I. (2020). Immune Checkpoint Inhibitors for the Treatment of Unresectable Stage III Non–Small Cell Lung Cancer: Emerging Mechanisms and Perspectives. Lung Cancer: Targets and Therapy, Volume 10, 161-170. https://doi.org/10.2147/lctt.s184380
Vancouver
Inoue H, Okamoto I. Immune Checkpoint Inhibitors for the Treatment of Unresectable Stage III Non–Small Cell Lung Cancer: Emerging Mechanisms and Perspectives. Lung Cancer: Targets and Therapy. 2020;Volume 10:161-170. doi:10.2147/lctt.s184380
BibTeX
@article{Inoue2020,
author = {Inoue, Hiroyuki and Okamoto, Isamu},
title = {Immune Checkpoint Inhibitors for the Treatment of Unresectable Stage III Non–Small Cell Lung Cancer: Emerging Mechanisms and Perspectives},
journal = {Lung Cancer: Targets and Therapy},
year = {2020},
volume = {Volume 10},
pages = {161--170},
doi = {10.2147/lctt.s184380}
}
EUVIMED